Azenta Inc (OQ:AZTA)

Business Focus: Biotechnology & Medical Research

May 01, 2024 04:05 pm ET
Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and Webcast
BURLINGTON, Mass., May 1, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal second quarter 2024 earnings which ended on March 31, 2024, on Wednesday, May 8, 2024, after the market closes.
Apr 01, 2024 04:15 pm ET
Azenta Publishes its 2023 Environmental, Social, & Governance (ESG) Report
BURLINGTON, Mass., April 1, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the publication of its annual Environmental, Social, & Governance ("ESG") report, highlighting the Company's ongoing commitment to advancing its strategy and actions aligned with key ESG priorities. The report includes ESG data for the Company's fiscal year ended September 30, 2023.
Apr 01, 2024 04:05 pm ET
Azenta to Participate in the 23rd Annual Needham Virtual Healthcare Conference
BURLINGTON, Mass., April 1, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 23rd Annual Needham Virtual Healthcare Conference, on Monday, April 8, 2024, which includes a presentation beginning at 12:45 pm ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
Feb 07, 2024 03:05 pm ET
Azenta Reports First Quarter Results for Fiscal 2024, Ended December 31, 2023
BURLINGTON, Mass., Feb. 7, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the first quarter ended December 31, 2023.
Feb 02, 2024 07:00 am ET
Azenta Launches the BioArc™ Ultra, a Breakthrough, Automated Solution for Efficient, Eco-Friendly Ultracold Sample Management
BURLINGTON, Mass., Feb. 2, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the launch of the BioArc™ Ultra (the "Ultra"), a breakthrough, automated solution for high-density, eco-friendly ultracold sample management, designed to provide a new level of performance for large-scale sample management with the potential to forever change the landscape of biorepositories. The Ultra delivers significant operational efficiency benefits, including footprint, labor and electricity cost savings as compared to other commercially available systems, while enabling customers to further the
Jan 25, 2024 03:05 pm ET
Azenta Announces Fiscal 2024 First Quarter Earnings Conference Call and Webcast
BURLINGTON, Mass., Jan. 25, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal first quarter 2024 earnings which ended on December 31, 2023, on Wednesday, February 7, 2024, after the market closes.
Jan 11, 2024 03:05 pm ET
Azenta to Host Investor Day on March 14, 2024
BURLINGTON, Mass., Jan. 11, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it will host an Investor Day on Thursday, March 14, 2024 in New York City. The event will feature presentations from members of the executive leadership team outlining the Company's strategy and vision.
Jan 09, 2024 03:05 pm ET
Azenta to Participate in the 26th Annual Needham Growth Conference
BURLINGTON, Mass., Jan. 9, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 26th Annual Needham Growth Conference in New York, NY, on Thursday, January 18, 2024, which includes a presentation beginning at 10:15 am ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
Jan 03, 2024 03:05 pm ET
Azenta to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
BURLINGTON, Mass., Jan. 3, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on Thursday, January 11, 2024, at 7:30 am PST. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
Nov 21, 2023 03:05 pm ET
Azenta to Participate in the 6th Annual Evercore ISI HealthCONx Conference
BURLINGTON, Mass., Nov. 21, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in 1x1 meetings at the 6th Annual Evercore ISI HealthCONx Conference in Miami, FL, on Wednesday, November 29, 2023.
Nov 13, 2023 03:07 pm ET
Azenta Reports Fourth Quarter and Full Year Fiscal 2023 Results, Ended September 30, 2023
Q4'23 reported revenue growth of 25% year over year and 2% on an organic basisFY'23 reported revenue growth of 20% and down 1% on an organic basisQ4'23 generated positive free cash flow for the second consecutive quarterFiscal 2024 organic revenue growth expected to be 5-8% Committing to an additional $500 million in share repurchases in Fiscal 2024 BURLINGTON, Mass., Nov. 13, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the fourth quarter and fiscal year ended September 30, 2023.
Nov 13, 2023 03:06 pm ET
Azenta Announces Actions to Support Ongoing Strategic and Governance Transformation
Nominates Didier Hirsch and Martin Madaus for election to the Board of Directors Upon the election of Messrs. Hirsch and Madaus, seven of the Board of Directors' ten members will have been added since 2018Separately, Azenta today announced strong 2023 fourth quarter and full year fiscal 2023 earnings results, with commitment to additional $500 million in share repurchases in Fiscal 2024  BURLINGTON, Mass., Nov. 13, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced a series of actions as part of the Company's ongoing strategic and governance transformation.
Nov 13, 2023 03:05 pm ET
Azenta Announces Agreement Between B Medical and The Ministry of Public Health, Hygiene and Prevention of the Democratic Republic of the Congo for a Significant National Universal Health Project
BURLINGTON, Mass., Nov. 13, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that B Medical Systems S.à r.l ("B Medical") and The Ministry of Public Health, Hygiene and Prevention of the Democratic Republic of the Congo (DRC) (the "Ministry") have entered into a Memorandum of Understanding ("MOU") for B Medical to deliver a complete solution suitable for the storage and transport of vaccines with real-time traceability, as well as the delivery of Toyota vehicles, which have been customized with B Medical cold chain solutions, and other complementary equipment under a new €100
Nov 10, 2023 03:05 pm ET
Azenta to Participate in the Stephens Annual Investment Conference
BURLINGTON, Mass., Nov. 10, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Stephens Annual Investment Conference in Nashville, Tennessee, on Wednesday, November 15, 2023, and Thursday, November 16, 2023. The company will host a presentation on Thursday, November 16, 2023, beginning at 11:00 am CT. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
Nov 08, 2023 03:05 pm ET
Azenta Announces Fiscal 2023 Fourth Quarter and Full Year Earnings Conference Call and Webcast
BURLINGTON, Mass., Nov. 8, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2023 earnings which ended on September 30, 2023 on Monday, November 13, 2023 after the market closes.
Oct 19, 2023 04:05 pm ET
Azenta to Host GENEWIZ Week November 6-10, 2023
BURLINGTON, Mass., Oct. 19, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that GENEWIZ Multiomics and Synthesis Solutions from Azenta Life Sciences will be hosting GENEWIZ Week November 6-10, 2023. The weeklong event will feature various virtual educational workshops, exclusive promotions, and a special grant program to recognize excellence in genomics research.
Sep 26, 2023 08:00 am ET
Azenta Announces CFO Transition
Industry Veteran Herman Cueto Named CFO
Jun 29, 2023 04:05 pm ET
Azenta Announces New Biorepository in the Greater Boston Area
Azenta has selected the greater Boston area, a key pharma and biotech hub, as the next location to expand its global biorepository footprint.
May 30, 2023 04:05 pm ET
Azenta to Participate in the Jefferies Healthcare Conference
BURLINGTON, Mass., May 30, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Jefferies Healthcare Conference in New York, NY, on Thursday, June 8, 2023, which includes a presentation beginning at 11:30 am ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
May 24, 2023 08:00 am ET
Azenta Announces Collaboration with the Lupus Research Alliance to Support the Advancement of Lupus Research and Drug Discovery
Azenta has been Selected by the Lupus Research Alliance as its Sample Management Services Provider and Partner in Supporting the Development of the Patient Registry Component of the Lupus Nexus
May 17, 2023 04:05 pm ET
Azenta to Participate in the 23rd Annual B. Riley Securities Institutional Investor Conference
BURLINGTON, Mass., May 17, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 23rd Annual B. Riley Securities Institutional Investor Conference. To attend the event please contact your B. Riley Securities representative.
May 09, 2023 04:05 pm ET
Azenta Reports Results of Second Quarter of Fiscal 2023 and Announces Business Realignment
BURLINGTON, Mass., May 9, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the second quarter ended March 31, 2023.
May 03, 2023 04:05 pm ET
Azenta Announces Fiscal 2023 Second Quarter Earnings Conference Call and Webcast
BURLINGTON, Mass., May 3, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal second quarter 2023 earnings which ended on March 31, 2023 on Tuesday, May 9, 2023 after the market closes.
Apr 13, 2023 07:00 pm ET
Azenta to Participate in the 22nd Annual Needham Virtual Healthcare Conference
BURLINGTON, Mass., April 13, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 22nd Annual Needham Virtual Healthcare Conference on Tuesday, April 18, 2023, which includes a presentation beginning at 9:30 am ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
Mar 15, 2023 05:06 pm ET
Azenta to Participate in the Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
BURLINGTON, Mass., March 15, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023, which includes a presentation beginning at 4:30 pm ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
Feb 27, 2023 06:30 am ET
Azenta Launches Cryo Store Pico™, a Novel Automated Cryogenic Storage System Designed for Clinical and Laboratory Applications
An Extension of Azenta's Innovative and Market Leading Automated Cryogenic Technology
Feb 10, 2023 06:30 am ET
Azenta to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
BURLINGTON, Mass., Feb. 10, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 15-16, 2023. To attend the event please contact your BTIG representative.
Feb 08, 2023 03:05 pm ET
Azenta Reports First Quarter Results For Fiscal 2023, Ended December 31, 2022
Reported Q1'23 Revenue of $178 Million and Growth of 28% Year-Over-YearDelivered Organic Growth Excluding COVID of 7%Reducing Cost Structure to Deliver Two Points of Margin Enhancement in 2nd Half FY23BURLINGTON, Mass., Feb. 8, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the first quarter ended December 31, 2022.
Feb 06, 2023 03:35 pm ET
Azenta Announces Fiscal 2023 First Quarter Earnings Conference Call and Webcast
BURLINGTON, Mass., Feb. 6, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal first quarter 2023 earnings which ended on December 31, 2022 on Wednesday, February 8, 2023 after the market closes.
Feb 03, 2023 06:00 am ET
Azenta Announces the Acquisition of Ziath
Enhances high-throughput workflow offerings with leading 2D barcode reader
Jan 23, 2023 09:00 am ET
Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that Tina S. Nova, Ph.D. has been elected as Executive Chair of the Exagen Board of Directors, effective January 19, 2023. Dr. Nova succeeds Brian Birk,...
Jan 05, 2023 07:00 am ET
Azenta to participate in the 41st Annual J.P. Morgan Healthcare Conference
BURLINGTON, Mass., Jan. 5, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on Wednesday, January 11, 2023, which includes a presentation beginning at 3:45 pm PST. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
Jan 05, 2023 06:55 am ET
Azenta to participate in the 25th Annual Needham Growth Conference
BURLINGTON, Mass., Jan. 5, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 25th Annual Needham Growth Conference in New York, NY, on Wednesday, January 11, 2023, which includes a presentation beginning at 11:00 am ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
Nov 23, 2022 06:15 am ET
Azenta Announces $500 Million Accelerated Share Repurchase Agreement
CHELMSFORD, Mass., Nov. 23, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has entered into an accelerated share repurchase agreement ("ASR") with JP Morgan Chase Bank, N.A. (the "Dealer") to repurchase $500 million of the Company's common stock. The ASR was entered into pursuant to the Company's previously announced $1.5 billion share repurchase authorization. In addition to the ASR, the Company intends to repurchase at least an additional $500 million in common stock over the next year.
Nov 21, 2022 03:05 pm ET
Azenta to participate in the 5th Annual Evercore ISI HealthCONx Conference
CHELMSFORD, Mass., Nov. 21, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the virtual 5th Annual Evercore ISI HealthCONx Conference on Tuesday, November 29, 2022, which includes a presentation beginning at 3:30 pm ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
Nov 15, 2022 07:30 am ET
Thinking about buying stock in Azenta, Shoals Technologies, Sea, Lufax, or 4D Molecular Therapeutics?
NEW YORK, Nov. 15, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AZTA, SHLS, SE, LU, and FDMT.
Nov 14, 2022 03:09 pm ET
Azenta Announces Nomination of Tina S. Nova, Ph.D. and Dorothy E. Puhy to Board of Directors
CHELMSFORD, Mass., Nov. 14, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Tina S. Nova, Ph.D. and Dorothy E. Puhy have been nominated for election to its Board of Directors at the Company's 2023 Annual General Meeting. They will join as non-voting observers of the Company's Board of Directors with immediate effect.
Nov 09, 2022 07:30 am ET
Azenta to participate in the Stephens Annual Investment Conference
CHELMSFORD, Mass., Nov. 9, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Stephens Annual Investment Conference in Nashville, Tennessee, on Wednesday, November 16, 2022, which includes a presentation beginning at 12:00 pm CT. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
Nov 08, 2022 03:52 pm ET
Azenta and the Government of Luxembourg Announce a Memorandum of Understanding to Facilitate Continued Healthcare Technology Development in Luxembourg
CHELMSFORD, Mass., Nov. 8, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) and the Government of Luxembourg today announced the signing of a Memorandum of Understanding ("MoU") to facilitate continued healthcare technology development in Luxembourg. The Minister of the Economy of Luxembourg, Mr. Franz Fayot, and the President and CEO of Azenta, Steve Schwartz, signed the MoU at Azenta's Massachusetts-based global headquarters. Azenta, Inc. had recently acquired B Medical Systems, a leading global vaccine, and medical cold chain provider, based in Luxembourg.
Nov 07, 2022 03:38 pm ET
Azenta Announces Fiscal 2022 Fourth Quarter and Full Year Earnings Conference Call and Webcast
CHELMSFORD, Mass., Nov. 7, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2022 earnings which ended on September 30, 2022 on Monday, November 14, 2022 after the market closes.
Oct 03, 2022 04:05 pm ET
Azenta Announces Completion of B Medical Systems Acquisition
CHELMSFORD, Mass., Oct. 3, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has closed its previously announced acquisition of B Medical Systems S.á r.l and its subsidiaries ("B Medical"), a market leader in temperature-controlled storage and transportation solutions that enables the delivery of life-saving treatments to more than 150 countries worldwide. This acquisition complements Azenta's cold chain capabilities, adding differentiated solutions for reliable and traceable transport of temperature-sensitive specimens.
Sep 06, 2022 04:05 pm ET
Azenta to Participate in the Baird 2022 Global Healthcare Conference
CHELMSFORD, Mass., Sept. 6, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Baird 2022 Global Healthcare Conference in New York City, on Wednesday, September 14, 2022, which includes a presentation beginning at 9:40 am ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
Aug 30, 2022 04:05 pm ET
Azenta to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
CHELMSFORD, Mass., Aug. 30, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Morgan Stanley 20th Annual Global Healthcare Conference in New York City, on Tuesday, September 13, 2022, which includes a presentation beginning at 4:40 pm ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
Aug 11, 2022 04:05 pm ET
Azenta to Participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference
CHELMSFORD, Mass., Aug. 11, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on August 16, 2022.
Aug 09, 2022 04:20 pm ET
Azenta Life Sciences Reports Results of Third Quarter of Fiscal 2022, Ended June 30, 2022
CHELMSFORD, Mass., Aug. 9, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2022.
Aug 08, 2022 04:05 pm ET
Azenta Announces Agreement to Acquire B Medical Systems
Enhances Azenta's Leadership Position in Cold Chain Solutions and End-to-End Sample Management
Aug 05, 2022 04:05 pm ET
Azenta to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit
CHELMSFORD, Mass., Aug. 5, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the UBS Genomics 2.0 and MedTech Innovations Summit in Dana Point, CA, on Thursday, August 11, 2022, which includes a presentation beginning at 4:00 pm PT. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
Jul 27, 2022 04:05 pm ET
Azenta Celebrates Opening of New China Headquarters
CHELMSFORD, Mass., July 27, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the opening of its new China headquarters in Suzhou, which serves as the hub for Azenta operations in the Asia Pacific region.
Jul 13, 2022 04:05 pm ET
Azenta Reports Preliminary Results for Third Quarter of Fiscal 2022, Ended June 30, 2022 and Announces Earnings Conference Call and Webcast
CHELMSFORD, Mass., July 13, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported preliminary results for its third fiscal quarter ended June 30, 2022.
Jun 08, 2022 06:30 am ET
Azenta Announces Agreement to Acquire Barkey Holding GmbH
CHELMSFORD, Mass., June 8, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has entered into a definitive agreement to acquire Barkey Holding GmbH and its subsidiaries ("Barkey"), a leading provider of controlled rate thawing devices to medical, biotech and pharma industries. Barkey is headquartered in Leopoldshöhe, Germany.
Jun 02, 2022 04:05 pm ET
Azenta to Participate in the Jefferies Healthcare Conference
CHELMSFORD, Mass., June 2, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Jefferies Healthcare Conference in New York City, on Thursday, June 9, 2022, which includes a presentation beginning at 3:30 pm ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
May 19, 2022 08:00 am ET
Azenta to Participate in the UBS Global Healthcare Conference
CHELMSFORD, Mass., May 19, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the UBS Global Healthcare Conference in New York, on Tuesday, May 24, 2022, which includes a presentation beginning at 2:45 pm ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
May 09, 2022 04:05 pm ET
Azenta Life Sciences Reports Preliminary Results of Second Quarter of Fiscal 2022, Ended March 31, 2022
Robust customer demand bolstered by operational execution drives strong second quarter results
Apr 28, 2022 04:05 pm ET
Azenta Reschedules Fiscal 2022 Second Quarter Earnings Conference Call and Webcast
CHELMSFORD, Mass., April 28, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has rescheduled the release of its earnings for the second fiscal quarter of 2022 which ended on March 31, 2022 from Tuesday, May 3, 2022 to Monday, May 9, 2022 after the market closes. The change is due to a delay in completing the quarter-end closing process related to the sale of the Semiconductor Automation business, which closed on February 1, 2022.
Apr 14, 2022 04:05 pm ET
Azenta Life Sciences Announces Fiscal 2022 Second Quarter Earnings Conference Call and Webcast
CHELMSFORD, Mass., April 14, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal 2022 second quarter earnings which ended on March 31, 2022 on Tuesday, May 3, 2022 after the market closes.
Mar 30, 2022 04:05 pm ET
Azenta to Participate in the 21st Annual Needham Virtual Healthcare Conference
CHELMSFORD, Mass., March 30, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 21st Annual Needham Virtual Healthcare Conference on Tuesday, April 12, 2022, which includes a presentation beginning at 9:30am ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
Mar 11, 2022 07:00 am ET
Azenta to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
CHELMSFORD, Mass., March 11, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 22, 2022, which includes a presentation beginning at 3:00pm ET. The conference will be held in a virtual environment. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
Mar 01, 2022 03:05 pm ET
Azenta to Participate in the Barclays Global Healthcare Conference
CHELMSFORD, Mass., March 1, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Barclays Global Healthcare Conference on Tuesday, March 15, 2022, which includes a presentation beginning at 10:15am ET. The conference will be held in Miami, FL. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
Feb 25, 2022 07:00 am ET
Azenta to Participate in the Cowen 42nd Annual Health Care Conference
CHELMSFORD, Mass., Feb. 25, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in Cowen's 42nd Annual Health Care Conference on Tuesday, March 8, 2022, which includes a presentation beginning at 2:10pm ET. The conference will be held in a virtual environment. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
Feb 08, 2022 03:05 pm ET
Azenta Life Sciences Reports Results of First Quarter of Fiscal 2022, Ended December 31, 2021
CHELMSFORD, Mass., Feb. 8, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the fiscal quarter ended December 31, 2021.
Feb 04, 2022 03:05 pm ET
Azenta Life Sciences to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
CHELMSFORD, Mass., Feb. 4, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the virtual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Tuesday, February 15, 2022, which includes a presentation beginning at 10:30 a.m. EST. To join the virtual event, please contact your BTIG representative.
Feb 01, 2022 03:05 pm ET
Azenta Life Sciences Completes Sale of Semiconductor Solutions Group Business to Thomas H. Lee Partners
CHELMSFORD, Mass., Feb. 1, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has completed the previously announced sale of the company's Semiconductor Solutions Group business (or "automation business") to Thomas H. Lee Partners ("THL") for $3.0 billion in cash, subject to adjustments for working capital and other items.
Jan 06, 2022 03:05 pm ET
Azenta Life Sciences Names Matthew McManus Chief Operating Officer
CHELMSFORD, Mass., Jan. 6, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has appointed Matthew McManus Chief Operating Officer effective January 17th.  In this newly created role, Dr. McManus will oversee Life Sciences Products, Services, and all commercial operations of the business and will report directly to the CEO.
Jan 06, 2022 09:00 am ET
Azenta Life Sciences Expands Fleet of PacBio HiFi Sequencing Systems
PacBio (Nasdaq: PACB) today announced an expansion of its extensive suite of HiFi applications with Azenta Life Sciences, formerly GENEWIZ. The deal will increase PacBio’s HiFi sequencing platforms across Azenta’s newly combined company and support...
Dec 21, 2021 03:15 pm ET
Azenta Life Sciences to Participate in the 40th Annual J.P. Morgan Conference
CHELMSFORD, Mass., Dec. 21, 2021 /PRNewswire/ -- Azenta, Inc. (Nasdaq:AZTA) announced today that company management will participate in the 40th Annual J.P. Morgan Healthcare Conference.  The conference coordinators recently determined the event will be held in a virtual environment.  Azenta management will present via webcast on Wednesday, January 12, 2022 beginning at 3:45 p.m. EST which can be accessed through the Azenta investor relations website at www.investors.azenta.com/events.  A replay of the webcast will be available following the event.
Dec 20, 2021 03:15 pm ET
Azenta Life Sciences to Participate in the 24th Annual Needham Virtual Growth Conference
CHELMSFORD, Mass., Dec. 20, 2021 /PRNewswire/ -- Azenta, Inc. (Nasdaq:AZTA) announced today that company management will participate in the 24th Annual Needham Virtual Growth Conference on Monday, January 10, 2022 which includes a webcast beginning at 1:15 p.m. EST. The live webcast can be accessed through the Azenta investor relations website at www.investors.azenta.com/events. A replay of the webcast will be available following the event.

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.